Paul Fanikos, RPH, MPA/HA
Paul is responsible for providing leadership and oversight for the organization’s programs and services that focus on the development of evidence-based clinical practice guidelines, clinical outreach and education to providers and health systems to insure high-quality care for managing chronic conditions. Paul has more than 25 years experience directing disease and pharmaceutical educational programs that are focused on improving patient outcomes, containing costs, and optimizing customer satisfaction levels. Paul has held leadership roles with the country's largest pharmacy providers and pharmaceutical companies developing innovative solutions to challenges that impact healthcare practitioners, health systems, extended care facilities as well as homecare programs across the country. Paul received his pharmacy degree from Massachusetts College of Pharmacy and his Masters degree from Suffolk University.
Ellen Dancel, PharmD, MPH
Director of Clinical Materials Development
Ellen was a pharmacist at the Massachusetts General Hospital for ten years prior to joining Alosa Health, serving in various leadership roles. She received her MPH in epidemiology from Boston University where she worked on a project looking for potential economic efficiencies in the global donor-funded antiretroviral market. As Director of Clinical Materials Development, she leads the development of evidence-based, academic materials, in partnership with clinical experts, and oversees the production of clinical content from concept to completion.
Jing Luo, MD, MPH
Dr. Luo is a graduate of Duke University and the University of Illinois at Chicago College of Medicine. He completed his residency in primary care internal medicine at Yale-New Haven Hospital and fellowship in general internal medicine at the Brigham and Women’s Hospital. He received his MPH in clinical effectiveness at the Harvard T.H. Chan School of Public Health, is an Instructor of Medicine at Harvard Medical School and a faculty member of the Division of Pharmacoepidemiology and Pharmacoeconomics at the Brigham and Women’s Hospital. He supports the production of clinical materials and is one of the primary clinical consultants.
Rebecca Edelberg, MPH
Rebecca is responsible for providing technical and operational support to field staff, and for ensuring that field-based clinical education programs are executed to clients' satisfaction. Rebecca previously worked at Boston Medical Center implementing a clinical trial and as a consultant in the electronic medical records (EMR) industry, where she engaged in one-on-one clinician education. She has an undergraduate degree from Tufts University and a Masters in Public Health from Boston University with concentrations in Epidemiology and Health Policy.
Jerry Avorn, MD
Dr. Avorn is a graduate of Columbia College and Harvard Medical School; he completed his training in primary care internal medicine within the Harvard medical system. Dr. Avorn pioneered the concept of academic detailing in the 1980s, with the creation, deployment, and evaluation of the first such program. After testing it in a randomized trial in four state Medicaid programs, he went on to study the approach in nursing homes and demonstrated it significantly reduced overuse of antipsychotic drugs and improved the cognitive function of overmedicated patients. Both papers written on these trials were published in The New England Journal of Medicine. Dr. Avorn practiced internal medicine for over 30 years in ambulatory and in-hospital settings and helped to establish the program in geriatric medicine at Harvard. He is an expert in geriatric medication use, the study of adverse drug effects (particularly in patients with chronic disease), and medication cost-effectiveness analysis, and is the author of chapters on these subjects in the main textbooks in each field, as well being the author or co-author of over 400 papers in the medical literature. Dr. Avorn is a Professor of Medicine at Harvard Medical School and Chief of the Division of Pharmacoepidemiology and Pharmacoeconomics at Brigham & Women’s Hospital in Boston, one of the main Harvard teaching hospitals. In 2004 he participated in the founding of the Alosa Health, a non-profit organization dedicated to providing doctors with non-commercial education about medications. He was a co-author of the Institute of Medicine report on the development of trustworthy clinical guidelines, and the author of Powerful Medicines: The Benefits, Risks, and Costs of Prescription Drugs, published by Knopf and now in its 11th printing.
Michael Fischer, MD, MS
Dr. Fischer did his undergraduate work at Harvard College and attended Yale Medical School. At Brigham & Women’s Hospital, Dr. Fischer completed a residency in primary care medicine and has been practicing primary care since 2000. He received an MS degree in Clinical Effectiveness from the Harvard School of Public Health and is currently an Associate Professor of Medicine at Harvard Medical School. He is a widely published health services researcher studying the effects of reimbursement policies and other interventions on influencing physician prescribing and patient outcomes. For several years he headed the physician medication education program at BWH and has worked closely with Drs. Avorn and Choudhry on the Alosa Health programs of academic detailing since their inception in 2005. In this role, he has helped lead the creation of prescriber education materials and taken a central role in training academic detailers for several public sector programs. He is the Principal Investigator of the AHRQ-supported National Resource Center on Academic Detailing, which supports the creation and improvement of academic detailing programs throughout the country.
Niteesh Choudhry, MD, PhD
Dr. Choudhry is a Professor at Harvard Medical School and Executive Director of the Center for Healthcare Delivery Sciences (www.c4hds.org) at Brigham and Women’s Hospital, where he also Associate Physician in the Division of Pharmacoepidemiology and Pharmacoeconomics and a practicing Hospitalist. Much of Dr. Choudhry’s work has dealt with design and evaluation of novel strategies to overcome barriers to the broader use of evidence-based therapies. His work employs many research methods including large pragmatic randomized trials, predictive analytics, and cost-effectiveness modeling and is funded by a wide variety of sources including the NIH, non-profit foundations, and health insurers. Dr. Choudhry attended McGill University, received his MD and completed his residency training in Internal Medicine at the University of Toronto and then served as Chief Medical Resident for the Toronto General and Toronto Western Hospitals. He earned his PhD in Health Policy from Harvard University. He has published over 200 scientific papers in leading medical and policy journals and the quality of his work has been recognized by many national and international organizations. Dr. Choudhry practices inpatient general internal/hospital medicine and has won numerous awards for teaching excellence and mentorship including the George W. Thorn and the Jean Jackson Awards.
Brian Bateman, MD, MSc
Dr. Bateman is an Associate Professor of Anaesthesia at Harvard Medical School. He is the Chief of the Division of Obstetric Anesthesia in the Department of Anesthesiology, Perioperative, and Pain Medicine as well as researcher in the Division of Pharmacoepidemiology and Pharmacoeconomics at the Brigham and Women’s Hospital. His clinical practice is focused on obstetric anesthesia and anesthesia for general surgery. His research interests focus on the epidemiology of pregnancy complications and on pharmacoepidemiology in pregnancy and in the perioperative period. He is funded by the NIH. He is an associate editor at Anesthesiology. He is a standing member of the FDA Anesthetic and Analgesic Drug Products Advisory Committee. He received his Bachelor’s degree from Yale College where he was inducted into Phi Beta Kappa and Doctor of Medicine from Columbia University College of Physicians and Surgeons where he was inducted into Alpha Omega Alpha and was awarded the Janeway Prize for the highest academic achievement and abilities in the graduating class. He received a Masters of Science in Epidemiology from the Harvard School of Public Health. He completed an Internship in internal medicine at the Brigham and Women’s Hospital and a Residency and Chief Residency in Anesthesia, Critical Care, and Pain Medicine at the Massachusetts General Hospital.
Dae Kim, MD, MPH, ScD
Dr. Kim is a geriatrician and pharmacoepidemiologist at Brigham and Women's Hospital and Assistant Professor of Medicine at Harvard Medical School. As a clinical investigator, the main areas of his research include frailty assessment and drug safety evaluation in older adults. Dr. Kim provides primary and consultative care to older adults with multiple chronic conditions. Since 2014, he has been contributing to Alosa Health’s academic detailing program as a geriatrics expert.
Irina administers the flow of revenue and expenses, monthly reconciliations, financial reporting, and oversees the audit and budgeting processes. Irina has been working in non-profit accounting for eleven years. She has a degree in Mathematics from the University of Bucharest, Romania, and is currently pursuing a degree in Finance and Accounting Management at Northeastern University. She enjoys mathematical challenges and outdoor activities in the Boston area.
Business and Program Coordinator
Dan is the Business and Program Coordinator at Alosa Health. He graduated summa cum laude with a BA in English from the University of New Hampshire. His past work experience includes event planning and sponsorship negotiations, primarily in the medical education and biotech fields. In his free time, Dan plays guitar in a local band and enjoys traveling abroad.